(Q33927967)

30 July 2017

1 reference

title

Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis (English)

1 reference

30 July 2017

0 references

1 reference

1 reference

Karkkainen MJ

1

1 reference

30 July 2017

Petrova TV

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

30 July 2017

1 reference

30 July 2017

19

1 reference

30 July 2017

5598-5605

1 reference

30 July 2017

49

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203855

30 July 2017

0 references

cites work

Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular endothelial growth factor C induces angiogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Cellular survival: a play in three Akts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Structure, expression and receptor-binding properties of novel vascular endothelial growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Mapping of primary congenital lymphedema to the 5q35.3 region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Molecular and biological properties of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Role of tyrosine residues and protein interaction domains of SHC adaptor in VEGF receptor 3 signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Sck interacts with KDR and Flt-1 via its SH2 domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

A gene for lymphedema-distichiasis maps to 16q24.3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Neuropilin-1 is a placenta growth factor-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Current biology of VEGF-B and VEGF-C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Angiogenesis and vasculogenesis in treatment of cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Halting angiogenesis suppresses carcinoma cell invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

VEGFs, receptors and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203855

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203855

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference